OTCM
TRLHF
Market cap4mUSD
Mar 07, Last price
0.02USD
Name
Trellus Health PLC
Chart & Performance
P/E
—
P/S
127.51
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
19k
+5.56%
Net income
-6m
L-28.05%
CFO
-5m
L-38.82%
Earnings
Sep 24, 2025
Profile
Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | ||||
Revenues | 19 5.56% | 18 -28.00% | ||
Cost of revenue | 1,963 | 9,421 | ||
Unusual Expense (Income) | ||||
NOPBT | (1,944) | (9,403) | ||
NOPBT Margin | ||||
Operating Taxes | (123) | |||
Tax Rate | ||||
NOPAT | (1,944) | (9,280) | ||
Net income | (6,339) -28.05% | (8,810) 49.27% | ||
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | ||||
BB yield | ||||
| Debt | ||||
Debt current | ||||
Long-term debt | ||||
Deferred revenue | ||||
Other long-term liabilities | 822 | |||
Net debt | (12,166) | (19,085) | ||
| Cash flow | ||||
Cash from operating activities | (5,274) | (8,620) | ||
CAPEX | (2,908) | |||
Cash from investing activities | (2,351) | (2,908) | ||
Cash from financing activities | ||||
FCF | (1,921) | (9,256) | ||
| Balance | ||||
Cash | 12,166 | 19,085 | ||
Long term investments | ||||
Excess cash | 12,165 | 19,084 | ||
Stockholders' equity | (21,676) | (15,337) | ||
Invested Capital | 41,177 | 40,429 | ||
ROIC | ||||
ROCE | ||||
| EV | ||||
Common stock shares outstanding | 161,508 | 161,508 | ||
Price | 0.03 -67.50% | 0.10 -78.95% | ||
Market cap | 5,249 -67.50% | 16,151 -74.19% | ||
EV | (6,917) | 24 | ||
EBITDA | (1,228) | (8,867) | ||
EV/EBITDA | 5.63 | |||
Interest | ||||
Interest/NOPBT | ||||